Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Business
Bayer Touts Life Sciences R&D
by Alex Scott
December 8, 2014
| A version of this story appeared in
Volume 92, Issue 49
Bayer says it plans to “sharpen its focus” on innovation in life sciences. The firm spent a total of $4.4 billion on R&D in 2013, equivalent to 7.9% of sales, and expects to spend about the same amount in 2014. Bayer HealthCare accounts for 70% of R&D spending in life sciences with Bayer CropScience taking up the remainder. The firm has 13,000 staff involved in life sciences R&D, of which 61% are in health care and 39% are in crop science. In 2013, the life sciences businesses applied for 500 patents.
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter